Correction: Optomed Announces Clinical Trial Results
Optomed Plc Inside Information 7 February 2022 at 15.50, Helsinki Correction: Optomed Announces Clinical Trial Results Optomed corrects a mistake that was in the clinical trial results release announced today 7 February 2022. The correct specificity was 93.6 percent instead of the 93.0 percent that was included in the original release. The correct chapter: Among patients positive for more-than-mild diabetic retinopathy, the combined product, Aurora AEYE detected 91.9 percent (sensitivity), while patients without the eye disease were correctly identified 93.6